In The News
Zepbound Weight Loss Drug Is Now Available: Expert Answers for 10 Common Questions
Zepbound, a brand name for tirzepatide, was approved by the FDA for weight loss in November. It is a dual-agonist drug that activates GIP (glucose-dependent insulinotropic polypeptide or gastric inhibitory polypeptide) and GLP-1 (glucagon-like peptide-1) hormone receptors, aiding in glucose management and helping patients feel fuller longer. In trials, patients lost an average of 26% body weight during 88 weeks, a higher percentage than patients taking semaglutide.
This Is the #1 Weight Loss Mistake Most People Make, According to Obesity Doctors
It isn’t easy to lose weight. That's why diet books continuously become best sellers and why so many people are eager to try the latest trendy eating plan. Maybe you have your own laundry list of weight loss habits you’ve tried: cutting carbs, intermittent fasting, taking up running…and the list goes on.
Volume Eating Is A Weight Loss Strategy That Involves Eating More Food In A Calorie Deficit
True or false: Losing weight is all about eating less and burning more calories. The answer? False in some cases. One diet plan, for example, has gained popularity for supposedly allowing you to eat more food while still maintaining a calorie deficit: volume eating.
What Happens When You Stop Taking Mounjaro? Experts Explain What To Expect
Weight loss hacks always seem to be trending, but prescription, injectable medications, like Mounjaro, are changing the game when it comes to helping people shed significant pounds. Most of the news focuses on what happens when you start taking Mounjaro, but what happens when you stop?